Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma

Leukemia Research

Volumn 35, Issue 9, 2011, Pages 1241-1247

  Nguyen Pham, Thanh Nhan ^a   Im, Chang Min ^a   Thi Nguyen, Truc Anh ^a,b   Lim, Mi Seon ^a,b   Hong, Cheol Yi ^a   Kim, Mi Hyun ^a   Lee, Hyun Ju ^a   Lee, Youn Kyung ^a   Cho, Duck ^a   Ahn, Jae Sook ^a   Yang, Deok Hwan ^a   Kim, Yeo Kyeoung ^a   Chung, Ik Joo ^a,b   Kim, Hyeoung Joon ^a   Lee, Je Jung ^a,b  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Dendritic cells; Immunotherapy; Multiple myeloma; Natural killer cells

Indexed keywords

CD38 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 2; POLYINOSINIC POLYCYTIDYLIC ACID;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLE MYELOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HL-60 CELLS; HUMANS; INTERFERON TYPE I, RECOMBINANT; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MULTIPLE MYELOMA; POLYDEOXYRIBONUCLEOTIDES; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80051475297     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.03.032     Document Type: Article

References (31)

1. Kyle R.A., Rajkumar S.V. Multiple myeloma. Blood 2008, 111:2962-2972.
2. Reichardt V.L., Brossart P. Dendritic cells in clinical trials for multiple myeloma. Methods Mol Med 2005, 109:127-136.
3. Jonuleit H., Kuhn U., Muller G., et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997, 27:3135-3142.
4. Kalinski P., Hilkens C.M., Snijders A., Snijdewint F.G., Kapsenberg M.L. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997, 159:28-35.
5. Mailliard R.B., Wankowicz-Kalinska A., Cai Q., Wesa A., Hilkens C.M., Kapsenberg M.L., et al. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL inducing activity. Cancer Res 2004, 64:5934-5937.
6. Lee J.J., Foon K.A., Mailliard R.B., Muthuswamy R., Kalinski P. Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia. J Leukoc Biol 2008, 84:319-325.
7. Yang D.H., Kim M.H., Hong C.Y., Lee Y.K., Jin C.J., Pham T.N., Ahn J.S., Bae W.K., Kim Y.K., Chung I.J., Kim H.J., Kalinski P., Lee J.J. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Ann Hematol 2010, 89:795-801.
8. Fernandez N.C., Lozier A., Flament C., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999, 5:405-411.
9. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002, 195:343-351.
10. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002, 195:327-333.
11. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002, 195:335-341.
12. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., Caligiuri M.A. NK cell and DC interactions. Trends Immunol 2004, 25:47-52.
13. Mailliard R.B., Son Y.I., Redlinger R., et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003, 171:2366-2373.
14. Kalinski P., Giermasz A., Nakamura Y., et al. Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol 2005, 42:535-539.
15. Pham T.N., Hong C.Y., Min J.J., Rhee J.H., Nguyen T.A., Park B.C., Yang D.H., Park Y.K., Kim H.R., Chung I.J., Kim H.J., Lee J.J. Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist. Exp Mol Med 2010, 42:407-419.
16. Verdijk R.M., Mutis T., Esendam B., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 1999, 163:57-61.
17. Rouas R., Lewalle P., El Ouriaghli F., Nowak B., Duvillier H., Martiat P. Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Int Immunol 2004, 16:767-773.
18. Schmidt K.N., Leung B., Kwong M., et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004, 172:138-143.
19. Sivori S., Falco M., Della Chiesa M., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004, 101:10116-10121.
20. Akazawa T., Ebihara T., Okuno M., Antitumor N.K., et al. activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA 2007, 104:252-257.
21. Muthuswamy R., Urban J., Lee J.J., Reinhart T.A., Bartlett D., Kalinski P. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 2008, 68:5972-5978.
22. Jung T.Y., Pham T.N., Umeyama A., et al. Ursolic acid isolated from Uncaria rhynchophylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ naïve T cells. Eur J Pharmacol 2010, 643:297-303.
23. Kim S.K., Nguyen Pham T.N., Nguyen Hoang T.M., et al. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens. Ann Hematol 2009, 88:1113-1123.
24. Lee J.J., Choi B.H., Kang H.K., et al. Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates. Leukemia Lymphoma 2007, 48:2022-2031.
25. Fedele G., Frasca L., Palazzo R., Ferrero E., Malavasi F., Ausiello C.M. CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction. Eur J Immunol 2004, 34:1342-1350.
26. Frasca L., Fedele G., Deaglio S., et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 2006, 107:2392-2399.
27. Borg C., Jalil A., Laderach D., et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004, 104:3267-3275.
28. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity 2001, 14:661-664.
29. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., Tough D.F. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001, 14:461-470.
30. Vieira P.L., de Jong E.C., Wierenga E.A., Kapsenberg M.L., Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000, 164:4507-4512.
31. Mocikat R., Braumüller H., Gumy A., et al. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003, 19:561-569.